Hydroxyapatite is best evaluated against other biomedical materials by comparing bioactivity, processability, degradation, and fit for the target indication.
For biomaterials teams, composition, structure, process control, and end-use requirements should be reviewed together, because each one affects performance in the final application.
For that reason, material selection, manufacturing consistency, and the actual application context should be assessed together rather than in isolation.